Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jun, 2017 | Pages:
1799 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Colorectal Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H1 2017, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools and weight loss with no known reason. Treatment includes surgery, radiation therapy and chemotherapy. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Colorectal Cancer - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Colorectal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Colorectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colorectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 1, 25, 108, 137, 10, 173, 26 and 10 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 18, 9, 28 and 5 molecules, respectively. Colorectal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Colorectal Cancer (Oncology). - The pipeline guide reviews pipeline therapeutics for Colorectal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Colorectal Cancer (Oncology) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Colorectal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Colorectal Cancer (Oncology) Reasons To Buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Colorectal Cancer (Oncology). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Colorectal Cancer (Oncology) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2 Introduction 11 Colorectal Cancer - Overview 12 Colorectal Cancer - Therapeutics Development 13 Colorectal Cancer - Therapeutics Assessment 66 Colorectal Cancer - Companies Involved in Therapeutics Development 94 Colorectal Cancer - Drug Profiles 223 Colorectal Cancer - Dormant Projects 1708 Colorectal Cancer - Discontinued Products 1725 Colorectal Cancer - Product Development Milestones 1730 Appendix 1745
List of Tables
Number of Products under Development for Colorectal Cancer, H1 2017 Number of Products under Development by Companies, H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..5), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..6), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..7), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..8), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..9), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..10), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..11), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..12), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..13), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..14), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..15), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..16), H1 2017 Number of Products under Development by Universities/Institutes, H1 2017 Number of Products under Development by Universities/Institutes, H1 2017 (Contd..1), H1 2017 Number of Products under Development by Universities/Institutes, H1 2017 (Contd..2), H1 2017 Products under Development by Companies, H1 2017 Products under Development by Companies, H1 2017 (Contd..1), H1 2017 Products under Development by Companies, H1 2017 (Contd..2), H1 2017 Products under Development by Companies, H1 2017 (Contd..3), H1 2017 Products under Development by Companies, H1 2017 (Contd..4), H1 2017 Products under Development by Companies, H1 2017 (Contd..5), H1 2017 Products under Development by Companies, H1 2017 (Contd..6), H1 2017 Products under Development by Companies, H1 2017 (Contd..7), H1 2017 Products under Development by Companies, H1 2017 (Contd..8), H1 2017 Products under Development by Companies, H1 2017 (Contd..9), H1 2017 Products under Development by Companies, H1 2017 (Contd..10), H1 2017 Products under Development by Companies, H1 2017 (Contd..11), H1 2017 Products under Development by Companies, H1 2017 (Contd..12), H1 2017 Products under Development by Companies, H1 2017 (Contd..13), H1 2017 Products under Development by Companies, H1 2017 (Contd..14), H1 2017 Products under Development by Companies, H1 2017 (Contd..15), H1 2017 Products under Development by Companies, H1 2017 (Contd..16), H1 2017 Products under Development by Companies, H1 2017 (Contd..17), H1 2017 Products under Development by Companies, H1 2017 (Contd..18), H1 2017 Products under Development by Companies, H1 2017 (Contd..19), H1 2017 Products under Development by Companies, H1 2017 (Contd..20), H1 2017 Products under Development by Companies, H1 2017 (Contd..21), H1 2017 Products under Development by Companies, H1 2017 (Contd..22), H1 2017 Products under Development by Companies, H1 2017 (Contd..23), H1 2017 Products under Development by Companies, H1 2017 (Contd..24), H1 2017 Products under Development by Companies, H1 2017 (Contd..25), H1 2017 Products under Development by Universities/Institutes, H1 2017 Products under Development by Universities/Institutes, H1 2017 (Contd..1), H1 2017 Products under Development by Universities/Institutes, H1 2017 (Contd..2), H1 2017 Products under Development by Universities/Institutes, H1 2017 (Contd..3), H1 2017 Number of Products by Stage and Target, H1 2017 Number of Products by Stage and Target, H1 2017 (Contd..1), H1 2017 Number of Products by Stage and Target, H1 2017 (Contd..2), H1 2017 Number of Products by Stage and Target, H1 2017 (Contd..3), H1 2017 Number of Products by Stage and Target, H1 2017 (Contd..4), H1 2017 Number of Products by Stage and Target, H1 2017 (Contd..5), H1 2017 Number of Products by Stage and Target, H1 2017 (Contd..6), H1 2017 Number of Products by Stage and Target, H1 2017 (Contd..7), H1 2017 Number of Products by Stage and Target, H1 2017 (Contd..8), H1 2017 Number of Products by Stage and Target, H1 2017 (Contd..9), H1 2017 Number of Products by Stage and Target, H1 2017 (Contd..10), H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1), H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..2), H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..3), H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..4), H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..5), H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..6), H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..7), H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..8), H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..9), H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..10), H1 2017 Number of Products by Stage and Route of Administration, H1 2017 Number of Products by Stage and Molecule Type, H1 2017 Colorectal Cancer - Pipeline by 2cureX ApS, H1 2017 Colorectal Cancer - Pipeline by 3-V Biosciences Inc, H1 2017 Colorectal Cancer - Pipeline by 3SBio Inc, H1 2017 Colorectal Cancer - Pipeline by 4SC AG, H1 2017 Colorectal Cancer - Pipeline by AB Science SA, H1 2017 Colorectal Cancer - Pipeline by AbbVie Inc, H1 2017 Colorectal Cancer - Pipeline by AbGenomics International Inc, H1 2017 Colorectal Cancer - Pipeline by Adamed Sp z oo, H1 2017 Colorectal Cancer - Pipeline by Aduro BioTech Inc, H1 2017 Colorectal Cancer - Pipeline by Advenchen Laboratories LLC, H1 2017 Colorectal Cancer - Pipeline by Alchemia Ltd, H1 2017 Colorectal Cancer - Pipeline by Allinky Biopharma, H1 2017 Colorectal Cancer - Pipeline by amcure GmbH, H1 2017 Colorectal Cancer - Pipeline by Amgen Inc, H1 2017 Colorectal Cancer - Pipeline by Antibe Therapeutics Inc, H1 2017 Colorectal Cancer - Pipeline by APEIRON Biologics AG, H1 2017 Colorectal Cancer - Pipeline by Apexigen Inc, H1 2017 Colorectal Cancer - Pipeline by Aphios Corp, H1 2017 Colorectal Cancer - Pipeline by Aposense Ltd, H1 2017 Colorectal Cancer - Pipeline by ARMO Biosciences Inc, H1 2017 Colorectal Cancer - Pipeline by ArQule Inc, H1 2017 Colorectal Cancer - Pipeline by Array BioPharma Inc, H1 2017 Colorectal Cancer - Pipeline by Asana BioSciences LLC, H1 2017 Colorectal Cancer - Pipeline by Aslan Pharmaceuticals Pte Ltd, H1 2017 Colorectal Cancer - Pipeline by Astellas Pharma Inc, H1 2017 Colorectal Cancer - Pipeline by Astex Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by AstraZeneca Plc, H1 2017 Colorectal Cancer - Pipeline by Aurobindo Pharma Ltd, H1 2017 Colorectal Cancer - Pipeline by AVEO Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by B Cell Design SAS, H1 2017 Colorectal Cancer - Pipeline by Basilea Pharmaceutica Ltd, H1 2017 Colorectal Cancer - Pipeline by Bavarian Nordic A/S, H1 2017 Colorectal Cancer - Pipeline by Bayer AG, H1 2017 Colorectal Cancer - Pipeline by BeiGene (Beijing) Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Beijing Hanmi Pharmaceutical Co Ltd, H1 2017 Colorectal Cancer - Pipeline by BeyondSpring Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Biocon Ltd, H1 2017 Colorectal Cancer - Pipeline by Bionomics Ltd, H1 2017 Colorectal Cancer - Pipeline by Bionovis SA, H1 2017 Colorectal Cancer - Pipeline by Biotecnol Ltd, H1 2017 Colorectal Cancer - Pipeline by Biothera Pharmaceutical Inc, H1 2017 Colorectal Cancer - Pipeline by Boehringer Ingelheim GmbH, H1 2017 Colorectal Cancer - Pipeline by Boston Biomedical Inc, H1 2017 Colorectal Cancer - Pipeline by Bristol-Myers Squibb Company, H1 2017 Colorectal Cancer - Pipeline by Burzynski Research Institute Inc, H1 2017 Colorectal Cancer - Pipeline by Calithera Biosciences Inc, H1 2017 Colorectal Cancer - Pipeline by Cancer Prevention Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Carna Biosciences Inc, H1 2017 Colorectal Cancer - Pipeline by Cascadian Therapeutics Inc, H1 2017 Colorectal Cancer - Pipeline by CBT Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by CCRP Therapeutics GmbH, H1 2017 Colorectal Cancer - Pipeline by Celgene Corp, H1 2017 Colorectal Cancer - Pipeline by Celldex Therapeutics Inc, H1 2017 Colorectal Cancer - Pipeline by Cellectar Biosciences Inc, H1 2017 Colorectal Cancer - Pipeline by Celleron Therapeutics Ltd, H1 2017 Colorectal Cancer - Pipeline by Celltrion Inc, H1 2017 Colorectal Cancer - Pipeline by Celyad SA, H1 2017 Colorectal Cancer - Pipeline by Chipscreen Biosciences Ltd, H1 2017 Colorectal Cancer - Pipeline by ChoDang Pharm Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Chong Kun Dang Pharmaceutical Corp, H1 2017 Colorectal Cancer - Pipeline by Cipla Ltd, H1 2017 Colorectal Cancer - Pipeline by Cleave Biosciences Inc, H1 2017 Colorectal Cancer - Pipeline by Cleveland BioLabs Inc, H1 2017 Colorectal Cancer - Pipeline by COARE Biotechnology Inc, H1 2017 Colorectal Cancer - Pipeline by Coherus BioSciences Inc, H1 2017 Colorectal Cancer - Pipeline by Compugen Ltd, H1 2017 Colorectal Cancer - Pipeline by Conatus Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Confluence Life Sciences Inc, H1 2017 Colorectal Cancer - Pipeline by Corvus Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Critical Outcome Technologies Inc, H1 2017 Colorectal Cancer - Pipeline by CrystalGenomics Inc, H1 2017 Colorectal Cancer - Pipeline by Daiichi Sankyo Company Ltd, H1 2017 Colorectal Cancer - Pipeline by DanDrit Biotech A/S, H1 2017 Colorectal Cancer - Pipeline by Deciphera Pharmaceuticals LLC, H1 2017 Colorectal Cancer - Pipeline by Dicerna Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Dr. Reddy's Laboratories Ltd, H1 2017 Colorectal Cancer - Pipeline by Eisai Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Eli Lilly and Company, H1 2017 Colorectal Cancer - Pipeline by Endor Nanotechnologies SL, H1 2017 Colorectal Cancer - Pipeline by EnGeneIC Ltd, H1 2017 Colorectal Cancer - Pipeline by Ensol Biosciences Inc, H1 2017 Colorectal Cancer - Pipeline by EntreChem SL, H1 2017 Colorectal Cancer - Pipeline by Enzene Biosciences Ltd, H1 2017 Colorectal Cancer - Pipeline by Enzo Biochem Inc, H1 2017 Colorectal Cancer - Pipeline by EpiThany Inc, H1 2017 Colorectal Cancer - Pipeline by Etubics Corp, H1 2017 Colorectal Cancer - Pipeline by Exelixis Inc, H1 2017 Colorectal Cancer - Pipeline by Exicure Inc, H1 2017 Colorectal Cancer - Pipeline by F-star Biotechnology Ltd, H1 2017 Colorectal Cancer - Pipeline by F. Hoffmann-La Roche Ltd, H1 2017 Colorectal Cancer - Pipeline by Formosa Laboratories Inc, H1 2017 Colorectal Cancer - Pipeline by Forty Seven Inc, H1 2017 Colorectal Cancer - Pipeline by Fusion Antibodies Ltd, H1 2017 Colorectal Cancer - Pipeline by Gene Techno Science Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Genentech Inc, H1 2017 Colorectal Cancer - Pipeline by Genor BioPharma Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Genoscience Pharma, H1 2017 Colorectal Cancer - Pipeline by Genzyme Corp, H1 2017 Colorectal Cancer - Pipeline by Gilead Sciences Inc, H1 2017 Colorectal Cancer - Pipeline by GlaxoSmithKline Plc, H1 2017 Colorectal Cancer - Pipeline by Glenmark Pharmaceuticals Ltd, H1 2017 Colorectal Cancer - Pipeline by Glycostem Therapeutics BV, H1 2017 Colorectal Cancer - Pipeline by Glycotope GmbH, H1 2017 Colorectal Cancer - Pipeline by Green Cross Corp, H1 2017 Colorectal Cancer - Pipeline by Hadasit Medical Research Services & Development Ltd, H1 2017 Colorectal Cancer - Pipeline by Handok Inc, H1 2017 Colorectal Cancer - Pipeline by Hanmi Pharmaceuticals Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Heat Biologics Inc, H1 2017 Colorectal Cancer - Pipeline by Hemispherx Biopharma Inc, H1 2017 Colorectal Cancer - Pipeline by Humorigin Biotechnology Corp, H1 2017 Colorectal Cancer - Pipeline by Hutchison China MediTech Ltd, H1 2017 Colorectal Cancer - Pipeline by iDD biotech SAS, H1 2017 Colorectal Cancer - Pipeline by Ideaya Biosciences Inc, H1 2017 Colorectal Cancer - Pipeline by Ignyta Inc, H1 2017 Colorectal Cancer - Pipeline by Ildong Pharmaceutical Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Immodulon Therapeutics Ltd, H1 2017 Colorectal Cancer - Pipeline by ImmuneXcite Inc, H1 2017 Colorectal Cancer - Pipeline by Immunomedics Inc, H1 2017 Colorectal Cancer - Pipeline by Immunovative Therapies Ltd, H1 2017 Colorectal Cancer - Pipeline by Incanthera Ltd, H1 2017 Colorectal Cancer - Pipeline by Incyte Corp, H1 2017 Colorectal Cancer - Pipeline by Innovation Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Innovent Biologics Inc, H1 2017 Colorectal Cancer - Pipeline by Inovio Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Interprotein Corp, H1 2017 Colorectal Cancer - Pipeline by Intezyne Technologies Inc, H1 2017 Colorectal Cancer - Pipeline by Ionis Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Isofol Medical AB, H1 2017 Colorectal Cancer - Pipeline by Jeil Pharmaceutical Co Ltd, H1 2017 Colorectal Cancer - Pipeline by JHL Biotech Inc, H1 2017 Colorectal Cancer - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Johnson & Johnson, H1 2017 Colorectal Cancer - Pipeline by KaloBios Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Kancera AB, H1 2017 Colorectal Cancer - Pipeline by Karyopharm Therapeutics Inc, H1 2017 Colorectal Cancer - Pipeline by Kura Oncology Inc, H1 2017 Colorectal Cancer - Pipeline by Laboratorio ELEA SACIF y A, H1 2017 Colorectal Cancer - Pipeline by Lion Biotechnologies Inc, H1 2017 Colorectal Cancer - Pipeline by LipoMedix Pharmaceutical Inc, H1 2017 Colorectal Cancer - Pipeline by Lipopharma Therapeutics SL, H1 2017 Colorectal Cancer - Pipeline by Loxo Oncology Inc, H1 2017 Colorectal Cancer - Pipeline by Mabion SA, H1 2017 Colorectal Cancer - Pipeline by MacroGenics Inc, H1 2017 Colorectal Cancer - Pipeline by Mantis Therapeutics BV, H1 2017 Colorectal Cancer - Pipeline by Marina Biotech Inc, H1 2017 Colorectal Cancer - Pipeline by MediaPharma Srl, H1 2017 Colorectal Cancer - Pipeline by MedImmune LLC, H1 2017 Colorectal Cancer - Pipeline by Medinet Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Merck & Co Inc, H1 2017 Colorectal Cancer - Pipeline by Merck KGaA, H1 2017 Colorectal Cancer - Pipeline by Merrimack Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Merus NV, H1 2017 Colorectal Cancer - Pipeline by Microlin Bio Inc, H1 2017 Colorectal Cancer - Pipeline by Molecular Partners AG, H1 2017 Colorectal Cancer - Pipeline by MolMed SpA, H1 2017 Colorectal Cancer - Pipeline by Mologen AG, H1 2017 Colorectal Cancer - Pipeline by Morphotek Inc, H1 2017 Colorectal Cancer - Pipeline by Multimmune GmbH, H1 2017 Colorectal Cancer - Pipeline by Mycenax Biotech Inc, H1 2017 Colorectal Cancer - Pipeline by NantKwest Inc, H1 2017 Colorectal Cancer - Pipeline by Natco Pharma Ltd, H1 2017 Colorectal Cancer - Pipeline by NatureWise Biotech & Medicals Corp, H1 2017 Colorectal Cancer - Pipeline by Nektar Therapeutics, H1 2017 Colorectal Cancer - Pipeline by Neovacs SA, H1 2017 Colorectal Cancer - Pipeline by Nerviano Medical Sciences Srl, H1 2017 Colorectal Cancer - Pipeline by Nippon Kayaku Co Ltd, H1 2017 Colorectal Cancer - Pipeline by NormOxys Inc, H1 2017 Colorectal Cancer - Pipeline by Northwest Biotherapeutics Inc, H1 2017 Colorectal Cancer - Pipeline by Novartis AG, H1 2017 Colorectal Cancer - Pipeline by Novogen Ltd, H1 2017 Colorectal Cancer - Pipeline by Noxxon Pharma AG, H1 2017 Colorectal Cancer - Pipeline by NuCana BioMed Ltd, H1 2017 Colorectal Cancer - Pipeline by OBI Pharma Inc, H1 2017 Colorectal Cancer - Pipeline by Omnitura Therapeutics Inc, H1 2017 Colorectal Cancer - Pipeline by Oncobiologics Inc, H1 2017 Colorectal Cancer - Pipeline by Oncology Research International Ltd, H1 2017 Colorectal Cancer - Pipeline by Oncolytics Biotech Inc, H1 2017 Colorectal Cancer - Pipeline by OncoMed Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Onconova Therapeutics Inc, H1 2017 Colorectal Cancer - Pipeline by Ono Pharmaceutical Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Oryx GmbH & Co KG, H1 2017 Colorectal Cancer - Pipeline by Otsuka Holdings Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Oxford BioMedica Plc, H1 2017 Colorectal Cancer - Pipeline by Pfizer Inc, H1 2017 Colorectal Cancer - Pipeline by Pharma Mar SA, H1 2017 Colorectal Cancer - Pipeline by PharmAbcine Inc, H1 2017 Colorectal Cancer - Pipeline by Pivotal BioSciences Inc, H1 2017 Colorectal Cancer - Pipeline by PlantForm Corp, H1 2017 Colorectal Cancer - Pipeline by Plexxikon Inc, H1 2017 Colorectal Cancer - Pipeline by PLx Pharma Inc, H1 2017 Colorectal Cancer - Pipeline by Precision Biologics Inc, H1 2017 Colorectal Cancer - Pipeline by Prima BioMed Ltd, H1 2017 Colorectal Cancer - Pipeline by Propanac Biopharma Inc, H1 2017 Colorectal Cancer - Pipeline by Provectus Biopharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by PsiOxus Therapeutics Ltd, H1 2017 Colorectal Cancer - Pipeline by Puma Biotechnology Inc, H1 2017 Colorectal Cancer - Pipeline by Puretech Health plc, H1 2017 Colorectal Cancer - Pipeline by Quintessence Biosciences Inc, H1 2017 Colorectal Cancer - Pipeline by R Pharm, H1 2017 Colorectal Cancer - Pipeline by Rafael Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by RedHill Biopharma Ltd, H1 2017 Colorectal Cancer - Pipeline by Redx Pharma Plc, H1 2017 Colorectal Cancer - Pipeline by Rexahn Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Rgenix Inc, H1 2017 Colorectal Cancer - Pipeline by Rhizen Pharmaceuticals SA, H1 2017 Colorectal Cancer - Pipeline by Richter Gedeon Nyrt, H1 2017 Colorectal Cancer - Pipeline by Samumed LLC, H1 2017 Colorectal Cancer - Pipeline by Sanofi, H1 2017 Colorectal Cancer - Pipeline by Selvita SA, H1 2017 Colorectal Cancer - Pipeline by Siamab Therapeutics Inc, H1 2017 Colorectal Cancer - Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Sigma-Tau SpA, H1 2017 Colorectal Cancer - Pipeline by Sigmoid Pharma Ltd, H1 2017 Colorectal Cancer - Pipeline by Sillajen Biotherapeutics, H1 2017 Colorectal Cancer - Pipeline by Simcere Pharmaceutical Group, H1 2017 Colorectal Cancer - Pipeline by Sorrento Therapeutics Inc, H1 2017 Colorectal Cancer - Pipeline by Steba Biotech SA, H1 2017 Colorectal Cancer - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H1 2017 Colorectal Cancer - Pipeline by SuviCa Inc, H1 2017 Colorectal Cancer - Pipeline by Symphogen A/S, H1 2017 Colorectal Cancer - Pipeline by SynDevRx Inc, H1 2017 Colorectal Cancer - Pipeline by Synermore Biologics Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Taiho Pharmaceutical Co Ltd, H1 2017 Colorectal Cancer - Pipeline by TaiwanJ Pharmaceuticals Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Takeda Pharmaceutical Company Ltd, H1 2017 Colorectal Cancer - Pipeline by Targovax ASA, H1 2017 Colorectal Cancer - Pipeline by Tarrex Biopharma Ltd, H1 2017 Colorectal Cancer - Pipeline by Tiltan Pharma Ltd, H1 2017 Colorectal Cancer - Pipeline by Tocagen Inc, H1 2017 Colorectal Cancer - Pipeline by TRACON Pharmaceuticals Inc, H1 2017 Colorectal Cancer - Pipeline by Transgene SA, H1 2017 Colorectal Cancer - Pipeline by United BioPharma Inc, H1 2017 Colorectal Cancer - Pipeline by Vaccinex Inc, H1 2017 Colorectal Cancer - Pipeline by VasGene Therapeutics Inc, H1 2017 Colorectal Cancer - Pipeline by Vaximm AG, H1 2017 Colorectal Cancer - Pipeline by ViiV Healthcare Ltd, H1 2017 Colorectal Cancer - Pipeline by Vitality Biopharma Inc, H1 2017 Colorectal Cancer - Pipeline by Wellstat Biologics Corp, H1 2017 Colorectal Cancer - Pipeline by Wilex AG, H1 2017 Colorectal Cancer - Pipeline by WntResearch AB, H1 2017 Colorectal Cancer - Pipeline by Wuhan YZY Biopharma Co Ltd, H1 2017 Colorectal Cancer - Pipeline by XBiotech Inc, H1 2017 Colorectal Cancer - Pipeline by XuanZhu Pharma Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Yabao Pharmaceutical Group Co Ltd, H1 2017 Colorectal Cancer - Pipeline by Zymeworks Inc, H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..1), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..2), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..3), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..4), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..5), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..6), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..7), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..8), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..9), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..10), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..11), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..12), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..13), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..14), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..15), H1 2017 Colorectal Cancer - Dormant Projects, H1 2017 (Contd..16), H1 2017 Colorectal Cancer - Discontinued Products, H1 2017 Colorectal Cancer - Discontinued Products, H1 2017 (Contd..1), H1 2017 Colorectal Cancer - Discontinued Products, H1 2017 (Contd..2), H1 2017 Colorectal Cancer - Discontinued Products, H1 2017 (Contd..3), H1 2017 Colorectal Cancer - Discontinued Products, H1 2017 (Contd..4), H1 2017
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
